Publication: 2476

Publication: 2476

Patient-Reported (EORTC QLQ-CIPN20) Versus Physician-Reported (CTCAE) Quantification of Oxaliplatin- and Paclitaxel/Carboplatin-Induced Peripheral Neuropathy in NCCTG/Alliance Clinical Trials

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Support Care Cancer vol 25 (11) 3537-44

Year:: 2017
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Meta-Analysis
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: Yes
Book Volume:: 7

Parents:: None
Children:: None

Program:: CCP
Primary Committee:: Symptom Inter
Sec. Committees:: Health Outcomes

Pharmas:
Grants:: R01 NR015259, U10 CA180790, UG1 CA189823, R01NR015259

Corr. Author:
Authors:: Jennifer Le-Rademacher Rahul Kanwar Drew Seisler Deirdre R. Pachman Rui Qin Alexej Abyzov Kathryn J. Ruddy Michaela S. Banck Ellen M. Lavoie Smith Susan G. Dorsey Neil K. Aaronson Jeff Sloan Charles L. Loprinzi Andreas S. Beutler

Networks:: LAPS-MN026

Study
Multiple Studies, or Legacy Studies in Alliance Study:: NCCTG-N08CA, NCCTG-N08CB
Phases:: 3

Keywords:: peripheral neuropathy, CTCAE, EORTC QLQ-CIPN20, patient-reported outcome, physician-reported outcome